Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Classifica tra le azioni #17273
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Prezzo delle azioni
$2.17
Capitalizzazione di mercato
$249.58M
Variazione (1 giorno)
-1.67%
Variazione (1 anno)
96.34%
Paese
CA
Scambia Cardiol Therapeutics Inc. (CRDL)

Categoria

Cronologia dei frazionamenti azionari per Cardiol Therapeutics Inc. (CRDL)
L’azione Cardiol Therapeutics Inc. (simbolo: CRDL) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Sep 02, 2026.
Una quota di CRDL acquistata prima di Sep 02, 2026 equivale oggi a 0 quote di CRDL.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti